These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 17549401)

  • 1. Down-regulation of uPAR and uPA activates caspase-mediated apoptosis and inhibits the PI3K/AKT pathway.
    Gondi CS; Kandhukuri N; Dinh DH; Gujrati M; Rao JS
    Int J Oncol; 2007 Jul; 31(1):19-27. PubMed ID: 17549401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. siRNA-mediated simultaneous downregulation of uPA and its receptor inhibits angiogenesis and invasiveness triggering apoptosis in breast cancer cells.
    Subramanian R; Gondi CS; Lakka SS; Jutla A; Rao JS
    Int J Oncol; 2006 Apr; 28(4):831-9. PubMed ID: 16525631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraperitoneal injection of a hairpin RNA-expressing plasmid targeting urokinase-type plasminogen activator (uPA) receptor and uPA retards angiogenesis and inhibits intracranial tumor growth in nude mice.
    Gondi CS; Lakka SS; Dinh DH; Olivero WC; Gujrati M; Rao JS
    Clin Cancer Res; 2007 Jul; 13(14):4051-60. PubMed ID: 17634529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA interference-mediated simultaneous down-regulation of urokinase-type plasminogen activator receptor and cathepsin B induces caspase-8-mediated apoptosis in SNB19 human glioma cells.
    Gondi CS; Kandhukuri N; Kondraganti S; Gujrati M; Olivero WC; Dinh DH; Rao JS
    Mol Cancer Ther; 2006 Dec; 5(12):3197-208. PubMed ID: 17172424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of the uPAR-uPA system retards angiogenesis, invasion, and in vivo tumor development in pancreatic cancer cells.
    Gorantla B; Asuthkar S; Rao JS; Patel J; Gondi CS
    Mol Cancer Res; 2011 Apr; 9(4):377-89. PubMed ID: 21389187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.
    Xue A; Xue M; Jackson C; Smith RC
    Int J Biochem Cell Biol; 2009; 41(8-9):1731-8. PubMed ID: 19433314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.
    Pulukuri SM; Gondi CS; Lakka SS; Jutla A; Estes N; Gujrati M; Rao JS
    J Biol Chem; 2005 Oct; 280(43):36529-40. PubMed ID: 16127174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of uPAR and cathepsin B retards cofilin dephosphorylation.
    Gondi CS; Kandhukuri N; Kondraganti S; Gujrati M; Olivero WC; Dinh DH; Rao JS
    Int J Oncol; 2006 Mar; 28(3):633-9. PubMed ID: 16465367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated urokinase-specific surface receptor expression is maintained through its interaction with urokinase plasminogen activator.
    Mahanivong C; Yu J; Huang S
    Mol Carcinog; 2007 Mar; 46(3):165-75. PubMed ID: 17186542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. uPA/uPAR downregulation inhibits radiation-induced migration, invasion and angiogenesis in IOMM-Lee meningioma cells and decreases tumor growth in vivo.
    Kargiotis O; Chetty C; Gogineni V; Gondi CS; Pulukuri SM; Kyritsis AP; Gujrati M; Klopfenstein JD; Dinh DH; Rao JS
    Int J Oncol; 2008 Nov; 33(5):937-47. PubMed ID: 18949356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
    Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
    Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphatidylinositol 3-kinase/Akt regulates the balance between plasminogen activator inhibitor-1 and urokinase to promote migration of SKOV-3 ovarian cancer cells.
    Whitley BR; Beaulieu LM; Carter JC; Church FC
    Gynecol Oncol; 2007 Feb; 104(2):470-9. PubMed ID: 17070899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA interference-mediated targeting of urokinase plasminogen activator receptor and matrix metalloproteinase-9 gene expression in the IOMM-lee malignant meningioma cell line inhibits tumor growth, tumor cell invasion and angiogenesis.
    Tummalapalli P; Gondi CS; Dinh DH; Gujrati M; Rao JS
    Int J Oncol; 2007 Jul; 31(1):5-17. PubMed ID: 17549400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic role of p53 is suppressed by si-RNA bicistronic construct of uPA, uPAR and cathepsin-B in meningiomas both in vitro and in vivo.
    Gupta R; Rao Gogineni V; Nalla AK; Chetty C; Klopfenstein JD; Tsung AJ; Mohanam S; Rao JS
    Int J Oncol; 2011 Apr; 38(4):973-83. PubMed ID: 21290090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous downregulation of uPAR and MMP-9 induces overexpression of the FADD-associated protein RIP and activates caspase 9-mediated apoptosis in gliomas.
    Gondi CS; Dinh DH; Gujrati M; Rao JS
    Int J Oncol; 2008 Oct; 33(4):783-90. PubMed ID: 18813792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNAi-mediated downregulation of urokinase plasminogen activator receptor and matrix metalloprotease-9 in human breast cancer cells results in decreased tumor invasion, angiogenesis and growth.
    Kunigal S; Lakka SS; Gondi CS; Estes N; Rao JS
    Int J Cancer; 2007 Nov; 121(10):2307-16. PubMed ID: 17657740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of uPA inhibits migration and PI3k/Akt signaling in glioblastoma cells.
    Chandrasekar N; Mohanam S; Gujrati M; Olivero WC; Dinh DH; Rao JS
    Oncogene; 2003 Jan; 22(3):392-400. PubMed ID: 12545160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD44 stimulation by fragmented hyaluronic acid induces upregulation of urokinase-type plasminogen activator and its receptor and subsequently facilitates invasion of human chondrosarcoma cells.
    Kobayashi H; Suzuki M; Kanayama N; Nishida T; Takigawa M; Terao T
    Int J Cancer; 2002 Dec; 102(4):379-89. PubMed ID: 12402308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SPARC-induced migration of glioblastoma cell lines via uPA-uPAR signaling and activation of small GTPase RhoA.
    Kunigal S; Gondi CS; Gujrati M; Lakka SS; Dinh DH; Olivero WC; Rao JS
    Int J Oncol; 2006 Dec; 29(6):1349-57. PubMed ID: 17088972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urokinase signaling through its receptor protects against anoikis by increasing BCL-xL expression levels.
    Alfano D; Iaccarino I; Stoppelli MP
    J Biol Chem; 2006 Jun; 281(26):17758-67. PubMed ID: 16632475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.